And notably, the finding of ‘macular atrophy’, a term describing atrophy developing under anti-VEGF therapy, has been a growing concern in that anti-VEGF therapy itself may contribute to the development of new atrophy of the outer retina29. The gene discussed is VEGFA; the disease is Atrophy.